It has been revealed that the injection of serotonin receptor antagonists, including the 5HT2 receptor, significantly increases adiponectin concentration in type 2 diabetes, which is accompanied by decreased plasma levels of adiponectin [27]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.